Quest Laboratories Past Earnings Performance
Past criteria checks 4/6
Quest Laboratories has been growing earnings at an average annual rate of 44.2%, while the Pharmaceuticals industry saw earnings growing at 13.4% annually. Revenues have been growing at an average rate of 16.7% per year. Quest Laboratories's return on equity is 14.8%, and it has net margins of 14%.
Key information
44.2%
Earnings growth rate
40.8%
EPS growth rate
| Pharmaceuticals Industry Growth | 17.5% |
| Revenue growth rate | 16.7% |
| Return on equity | 14.8% |
| Net Margin | 14.0% |
| Last Earnings Update | 30 Sep 2024 |
Revenue & Expenses Breakdown
How Quest Laboratories makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 842 | 118 | 38 | 0 |
| 30 Jun 24 | 834 | 109 | 41 | 0 |
| 31 Mar 24 | 826 | 101 | 43 | 0 |
| 31 Mar 23 | 616 | 50 | 34 | 0 |
| 31 Mar 22 | 595 | 41 | 35 | 0 |
| 31 Mar 21 | 304 | 7 | 24 | 0 |
| 31 Mar 20 | 264 | 3 | 17 | 0 |
Quality Earnings: QUESTLAB has a high level of non-cash earnings.
Growing Profit Margin: QUESTLAB's current net profit margins (14%) are higher than last year (10.5%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: QUESTLAB's earnings have grown significantly by 44.2% per year over the past 5 years.
Accelerating Growth: QUESTLAB's earnings growth over the past year (55.7%) exceeds its 5-year average (44.2% per year).
Earnings vs Industry: QUESTLAB earnings growth over the past year (55.7%) exceeded the Pharmaceuticals industry 20.5%.
Return on Equity
High ROE: QUESTLAB's Return on Equity (14.8%) is considered low.